Benzinga's Top Upgrades

Analysts at Deutsche Bank upgraded Verifone Systems

from “sell” to “hold.” The target price for Verifone has been raised from $18 to $19. Verifone's shares closed at $29.25 yesterday. Raymond James upgraded AngioDynamics

from “market perform” to “outperform.” The price target for AngioDynamics is set to $19. AngioDynamics' shares closed at $15.85 yesterday. Analysts at Longbow Research upgraded MRC Global

from “neutral” to “buy.” The price target for MRC Global is set to $34. MRC Global's shares closed at $26.03 yesterday. Goldman Sachs upgraded Rite Aid

from “neutral” to “buy.” Rite Aid's shares closed at $6.44 yesterday.